Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8038)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2019 (publication date) through May 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yuan XX, Zhu HJ, Pan H, Chen S, Liu ZY, Li Y, Wang LJ, Lu L, Yang HB, Gong FY. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. World J Gastroenterol 2019; 25(14): 1741-1752 [PMID: 31011258 DOI: 10.3748/wjg.v25.i14.1741] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i14/1741.htm |
| Number | Citing Articles |
| 1 |
Sara Arefhosseini, Mehrangiz Ebrahimi-Mameghani, Farzad Najafipour, Helda Tutunchi. Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1032361
|
| 2 |
Tingting Kong, Yunpeng Gu, Lei Sun, Run Zhou, Jie Li, Junping Shi. Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis. Endocrine Journal 2023; 70(10): 959 doi: 10.1507/endocrj.EJ23-0157
|
| 3 |
Zhaoxiang Liu, Wenhui Zhao, Chenxiang Cao, Yanlei Wang, Luqi Xiao, Xiaojing Wang, Chenxi Jin, Jianzhong Xiao. Pituitary stalk interruption syndrome and liver cirrhosis associated with diabetes and an inactivating KCNJ11 gene mutation: a case report and literature review. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1297146
|
| 4 |
Huan He, Dong Mei Li. One Case of Pituitary Stalk Interruption Syndrome Associated with Liver
Cirrhosis. Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23(9): 1229 doi: 10.2174/1871530323666230228110650
|
| 5 |
Bashir Ahmad Laway, Mohammad Salem Baba. Sheehan syndrome: Cardiovascular and metabolic comorbidities. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1086731
|
| 6 |
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2020; : 1 doi: 10.1007/978-3-319-66362-3_6-1
|
| 7 |
Jinfeng Xiao, Chonggui Zhu, Xinxin Zhang, Longhao Sun, Chang Gao, Xiaoyu Liang, Qing He, Ming Liu. Associations among FT<sub>4</sub> level, FT<sub>3</sub>/FT<sub>4</sub> ratio, and non-alcoholic fatty liver disease in Chinese patients with hypopituitarism. Endocrine Journal 2022; 69(6): 659 doi: 10.1507/endocrj.EJ21-0536
|
| 8 |
Agostino Di Ciaula, Grigorios Christidis, Marcin Krawczyk, Frank Lammert, Piero Portincasa. Endocrinology and Systemic Diseases. Endocrinology 2021; : 157 doi: 10.1007/978-3-319-68729-2_6
|
| 9 |
Qibin Huang, Hongli Xu, Xi Wang, Jiangfeng Mao, Bingqing Yu, Yiyi Zhu, Rui Zhang, Bang Sun, Junyi Zhang, Wen Ji, Wanlu Ma, Min Nie, Xueyan Wu. Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome. Clinical Endocrinology 2022; 97(5): 612 doi: 10.1111/cen.14732
|
| 10 |
Yoon-a Hwang, Hye Won Lee, Sang Hoon Ahn, Eun Jig Lee, Cheol Ryong Ku, Seung Up Kim. Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma. Frontiers in Endocrinology 2023; 13 doi: 10.3389/fendo.2022.1057769
|
| 11 |
Eréndira Villanueva-Ortega, Lucia A. Méndez-García, Guadalupe N. Garibay-Nieto, Estibalitz Laresgoiti-Servitje, Patricia Medina-Bravo, Alfonso Olivos-García, Martín H. Muñoz-Ortega, Javier Ventura-Juárez, Galileo Escobedo. Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppression. Growth Hormone & IGF Research 2020; : 101332 doi: 10.1016/j.ghir.2020.101332
|
| 12 |
Xinhe Zhang, Haoyu Tian, Yiling Li. The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease. iLIVER 2022; 1(1): 65 doi: 10.1016/j.iliver.2022.02.004
|
| 13 |
Hui Guan, Guangrui Shao, Fang Cheng, Pingjuan Ni, Mei Wu. Risk factors of nonalcoholic fatty liver disease in healthy women. Medicine 2023; 102(31): e34437 doi: 10.1097/MD.0000000000034437
|
| 14 |
Yan Hu, Chen Yuan, Muila Abdulnaimu, Jimilanmu Memetmin, Zhang Jie, Aihemaitijiang Tuhuti, Hanikzi Abudueini, Yanying Guo. U-Shaped relationship of insulin-like growth factor I and incidence of nonalcoholic fatty liver in patients with pituitary neuroendocrine tumors: a cohort study. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1290007
|
| 15 |
Ze-Yu Wu, Yi-Ling Li, Bing Chang. Pituitary stalk interruption syndrome and liver changes: From clinical features to mechanisms. World Journal of Gastroenterology 2020; 26(44): 6909-6922 doi: 10.3748/wjg.v26.i44.6909
|